nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ALB—Levothyroxine—hypothyroidism	0.14	0.206	CbGbCtD
Olanzapine—ALB—Liothyronine—hypothyroidism	0.14	0.206	CbGbCtD
Olanzapine—ALB—Liotrix—hypothyroidism	0.137	0.201	CbGbCtD
Olanzapine—ABCB1—Liothyronine—hypothyroidism	0.0734	0.108	CbGbCtD
Olanzapine—ABCB1—Levothyroxine—hypothyroidism	0.0734	0.108	CbGbCtD
Olanzapine—ABCB1—Liotrix—hypothyroidism	0.0716	0.105	CbGbCtD
Olanzapine—CYP3A4—Levothyroxine—hypothyroidism	0.044	0.0647	CbGbCtD
Olanzapine—FMO3—urine—hypothyroidism	0.0102	0.0544	CbGeAlD
Olanzapine—HTR2A—cerebellar cortex—hypothyroidism	0.00542	0.0289	CbGeAlD
Olanzapine—DRD1—nerve—hypothyroidism	0.0051	0.0272	CbGeAlD
Olanzapine—HTR3A—nerve—hypothyroidism	0.00493	0.0262	CbGeAlD
Olanzapine—CYP2C19—urine—hypothyroidism	0.00451	0.024	CbGeAlD
Olanzapine—HRH4—blood—hypothyroidism	0.00414	0.022	CbGeAlD
Olanzapine—DRD4—heart—hypothyroidism	0.00376	0.02	CbGeAlD
Olanzapine—CYP1A2—urine—hypothyroidism	0.00368	0.0196	CbGeAlD
Olanzapine—CYP2C9—urine—hypothyroidism	0.0035	0.0186	CbGeAlD
Olanzapine—HTR7—nerve—hypothyroidism	0.00319	0.017	CbGeAlD
Olanzapine—DRD2—nerve—hypothyroidism	0.00301	0.0161	CbGeAlD
Olanzapine—HTR2A—urine—hypothyroidism	0.00288	0.0153	CbGeAlD
Olanzapine—FMO3—adrenal cortex—hypothyroidism	0.0027	0.0144	CbGeAlD
Olanzapine—CYP3A4—urine—hypothyroidism	0.00267	0.0142	CbGeAlD
Olanzapine—CYP2D6—urine—hypothyroidism	0.00262	0.014	CbGeAlD
Olanzapine—FMO3—heart—hypothyroidism	0.00261	0.0139	CbGeAlD
Olanzapine—HRH2—heart—hypothyroidism	0.00233	0.0124	CbGeAlD
Olanzapine—DRD4—testis—hypothyroidism	0.00232	0.0124	CbGeAlD
Olanzapine—HTR1E—female gonad—hypothyroidism	0.00226	0.012	CbGeAlD
Olanzapine—HRH2—cardiovascular system—hypothyroidism	0.0022	0.0117	CbGeAlD
Olanzapine—FMO3—pituitary gland—hypothyroidism	0.00218	0.0116	CbGeAlD
Olanzapine—HTR2A—nerve—hypothyroidism	0.00199	0.0106	CbGeAlD
Olanzapine—H1F0—adrenal cortex—hypothyroidism	0.00198	0.0106	CbGeAlD
Olanzapine—FMO3—adrenal gland—hypothyroidism	0.00195	0.0104	CbGeAlD
Olanzapine—H1F0—heart—hypothyroidism	0.00192	0.0102	CbGeAlD
Olanzapine—FMO3—thyroid gland—hypothyroidism	0.00188	0.01	CbGeAlD
Olanzapine—H1F0—cardiovascular system—hypothyroidism	0.00181	0.00964	CbGeAlD
Olanzapine—CHRM4—testis—hypothyroidism	0.00176	0.00935	CbGeAlD
Olanzapine—HRH2—adrenal gland—hypothyroidism	0.00174	0.00925	CbGeAlD
Olanzapine—HRH2—blood—hypothyroidism	0.00174	0.00925	CbGeAlD
Olanzapine—DRD5—female gonad—hypothyroidism	0.00172	0.00919	CbGeAlD
Olanzapine—H1F0—gonad—hypothyroidism	0.00164	0.00875	CbGeAlD
Olanzapine—FMO3—testis—hypothyroidism	0.00161	0.0086	CbGeAlD
Olanzapine—H1F0—pituitary gland—hypothyroidism	0.0016	0.00854	CbGeAlD
Olanzapine—CHRM2—heart—hypothyroidism	0.00153	0.00813	CbGeAlD
Olanzapine—FMO3—liver—hypothyroidism	0.00153	0.00813	CbGeAlD
Olanzapine—HTR1B—cardiovascular system—hypothyroidism	0.00145	0.00771	CbGeAlD
Olanzapine—CHRM2—cardiovascular system—hypothyroidism	0.00144	0.00767	CbGeAlD
Olanzapine—ALB—heart—hypothyroidism	0.00143	0.00765	CbGeAlD
Olanzapine—H1F0—adrenal gland—hypothyroidism	0.00143	0.00762	CbGeAlD
Olanzapine—H1F0—blood—hypothyroidism	0.00143	0.00762	CbGeAlD
Olanzapine—HTR2B—adrenal cortex—hypothyroidism	0.00143	0.00761	CbGeAlD
Olanzapine—HTR1D—cardiovascular system—hypothyroidism	0.0014	0.00747	CbGeAlD
Olanzapine—HTR2B—heart—hypothyroidism	0.00138	0.00736	CbGeAlD
Olanzapine—H1F0—thyroid gland—hypothyroidism	0.00138	0.00736	CbGeAlD
Olanzapine—HTR3A—blood—hypothyroidism	0.00136	0.00727	CbGeAlD
Olanzapine—HRH2—liver—hypothyroidism	0.00136	0.00724	CbGeAlD
Olanzapine—H1F0—female gonad—hypothyroidism	0.00133	0.00711	CbGeAlD
Olanzapine—CHRM1—cardiovascular system—hypothyroidism	0.00131	0.00698	CbGeAlD
Olanzapine—HTR2B—cardiovascular system—hypothyroidism	0.0013	0.00695	CbGeAlD
Olanzapine—ORM1—blood—hypothyroidism	0.00122	0.00651	CbGeAlD
Olanzapine—H1F0—testis—hypothyroidism	0.00118	0.00631	CbGeAlD
Olanzapine—HTR7—heart—hypothyroidism	0.00118	0.0063	CbGeAlD
Olanzapine—HTR1A—cardiovascular system—hypothyroidism	0.00117	0.00622	CbGeAlD
Olanzapine—ADRA1A—heart—hypothyroidism	0.00114	0.00608	CbGeAlD
Olanzapine—ADRA2C—adrenal cortex—hypothyroidism	0.00112	0.00599	CbGeAlD
Olanzapine—H1F0—liver—hypothyroidism	0.00112	0.00596	CbGeAlD
Olanzapine—HTR7—cardiovascular system—hypothyroidism	0.00112	0.00595	CbGeAlD
Olanzapine—H1F0—cerebellum—hypothyroidism	0.00109	0.00582	CbGeAlD
Olanzapine—ADRA2C—heart—hypothyroidism	0.00109	0.00579	CbGeAlD
Olanzapine—ADRA1A—cardiovascular system—hypothyroidism	0.00108	0.00574	CbGeAlD
Olanzapine—ALB—adrenal gland—hypothyroidism	0.00107	0.00571	CbGeAlD
Olanzapine—HTR2B—adrenal gland—hypothyroidism	0.00103	0.00549	CbGeAlD
Olanzapine—HTR2B—blood—hypothyroidism	0.00103	0.00549	CbGeAlD
Olanzapine—HTR7—gonad—hypothyroidism	0.00101	0.0054	CbGeAlD
Olanzapine—HTR2B—thyroid gland—hypothyroidism	0.000995	0.0053	CbGeAlD
Olanzapine—ORM1—liver—hypothyroidism	0.000955	0.00509	CbGeAlD
Olanzapine—DRD2—pituitary gland—hypothyroidism	0.000935	0.00498	CbGeAlD
Olanzapine—HTR1A—adrenal gland—hypothyroidism	0.000924	0.00492	CbGeAlD
Olanzapine—ADRA2C—pituitary gland—hypothyroidism	0.000909	0.00484	CbGeAlD
Olanzapine—CYP2C9—heart—hypothyroidism	0.000896	0.00477	CbGeAlD
Olanzapine—CHRM3—thyroid gland—hypothyroidism	0.000895	0.00477	CbGeAlD
Olanzapine—ALB—testis—hypothyroidism	0.000886	0.00472	CbGeAlD
Olanzapine—HTR7—adrenal gland—hypothyroidism	0.000883	0.00471	CbGeAlD
Olanzapine—HTR7—blood—hypothyroidism	0.000883	0.0047	CbGeAlD
Olanzapine—ADRA2A—heart—hypothyroidism	0.000868	0.00462	CbGeAlD
Olanzapine—CHRM3—female gonad—hypothyroidism	0.000865	0.00461	CbGeAlD
Olanzapine—CYP2C19—blood—hypothyroidism	0.000862	0.00459	CbGeAlD
Olanzapine—ADRA1A—adrenal gland—hypothyroidism	0.000852	0.00454	CbGeAlD
Olanzapine—ADRA1A—blood—hypothyroidism	0.000852	0.00454	CbGeAlD
Olanzapine—CYP2C9—cardiovascular system—hypothyroidism	0.000845	0.0045	CbGeAlD
Olanzapine—ALB—liver—hypothyroidism	0.000837	0.00446	CbGeAlD
Olanzapine—ADRA2C—adrenal gland—hypothyroidism	0.000812	0.00432	CbGeAlD
Olanzapine—ADRA2C—blood—hypothyroidism	0.000811	0.00432	CbGeAlD
Olanzapine—CHRM3—testis—hypothyroidism	0.000767	0.00409	CbGeAlD
Olanzapine—ADRA2C—female gonad—hypothyroidism	0.000757	0.00403	CbGeAlD
Olanzapine—ADRA2A—gonad—hypothyroidism	0.000743	0.00396	CbGeAlD
Olanzapine—HTR2A—heart—hypothyroidism	0.000738	0.00393	CbGeAlD
Olanzapine—HTR7—testis—hypothyroidism	0.00073	0.00389	CbGeAlD
Olanzapine—ADRA2A—pituitary gland—hypothyroidism	0.000725	0.00386	CbGeAlD
Olanzapine—HTR1A—cerebellum—hypothyroidism	0.000706	0.00376	CbGeAlD
Olanzapine—CYP1A2—blood—hypothyroidism	0.000704	0.00375	CbGeAlD
Olanzapine—HTR2A—cardiovascular system—hypothyroidism	0.000696	0.00371	CbGeAlD
Olanzapine—DRD2—testis—hypothyroidism	0.00069	0.00368	CbGeAlD
Olanzapine—HTR7—liver—hypothyroidism	0.00069	0.00368	CbGeAlD
Olanzapine—CYP1A2—thyroid gland—hypothyroidism	0.00068	0.00362	CbGeAlD
Olanzapine—HTR7—cerebellum—hypothyroidism	0.000674	0.00359	CbGeAlD
Olanzapine—CYP2C19—liver—hypothyroidism	0.000674	0.00359	CbGeAlD
Olanzapine—ADRA2C—testis—hypothyroidism	0.000671	0.00358	CbGeAlD
Olanzapine—CYP2C9—blood—hypothyroidism	0.000668	0.00356	CbGeAlD
Olanzapine—ADRA1A—liver—hypothyroidism	0.000666	0.00355	CbGeAlD
Olanzapine—HRH1—adrenal gland—hypothyroidism	0.000659	0.00351	CbGeAlD
Olanzapine—ADRA1A—cerebellum—hypothyroidism	0.000651	0.00347	CbGeAlD
Olanzapine—ADRA2A—adrenal gland—hypothyroidism	0.000648	0.00345	CbGeAlD
Olanzapine—ADRA2A—blood—hypothyroidism	0.000647	0.00345	CbGeAlD
Olanzapine—DRD2—cerebellum—hypothyroidism	0.000638	0.0034	CbGeAlD
Olanzapine—ADRA2C—liver—hypothyroidism	0.000635	0.00338	CbGeAlD
Olanzapine—HTR2A—gonad—hypothyroidism	0.000632	0.00337	CbGeAlD
Olanzapine—ADRA2A—thyroid gland—hypothyroidism	0.000625	0.00333	CbGeAlD
Olanzapine—ADRA2C—cerebellum—hypothyroidism	0.00062	0.0033	CbGeAlD
Olanzapine—HTR2A—pituitary gland—hypothyroidism	0.000616	0.00328	CbGeAlD
Olanzapine—HRH1—female gonad—hypothyroidism	0.000615	0.00328	CbGeAlD
Olanzapine—ADRA2A—female gonad—hypothyroidism	0.000604	0.00322	CbGeAlD
Olanzapine—HTR2A—adrenal gland—hypothyroidism	0.000551	0.00293	CbGeAlD
Olanzapine—CYP1A2—liver—hypothyroidism	0.000551	0.00293	CbGeAlD
Olanzapine—HTR2A—blood—hypothyroidism	0.000551	0.00293	CbGeAlD
Olanzapine—HRH1—testis—hypothyroidism	0.000545	0.00291	CbGeAlD
Olanzapine—ADRA2A—testis—hypothyroidism	0.000536	0.00285	CbGeAlD
Olanzapine—CYP2C9—liver—hypothyroidism	0.000523	0.00279	CbGeAlD
Olanzapine—CYP3A4—blood—hypothyroidism	0.00051	0.00272	CbGeAlD
Olanzapine—CYP2D6—blood—hypothyroidism	0.000502	0.00267	CbGeAlD
Olanzapine—ABCB1—adrenal cortex—hypothyroidism	0.0005	0.00266	CbGeAlD
Olanzapine—ADRA2A—cerebellum—hypothyroidism	0.000495	0.00264	CbGeAlD
Olanzapine—ABCB1—heart—hypothyroidism	0.000483	0.00258	CbGeAlD
Olanzapine—CYP2D6—female gonad—hypothyroidism	0.000468	0.00249	CbGeAlD
Olanzapine—ABCB1—cardiovascular system—hypothyroidism	0.000456	0.00243	CbGeAlD
Olanzapine—HTR2A—testis—hypothyroidism	0.000455	0.00243	CbGeAlD
Olanzapine—HTR2A—liver—hypothyroidism	0.000431	0.00229	CbGeAlD
Olanzapine—HTR2A—cerebellum—hypothyroidism	0.000421	0.00224	CbGeAlD
Olanzapine—CYP2D6—testis—hypothyroidism	0.000415	0.00221	CbGeAlD
Olanzapine—ABCB1—gonad—hypothyroidism	0.000414	0.00221	CbGeAlD
Olanzapine—ABCB1—pituitary gland—hypothyroidism	0.000404	0.00215	CbGeAlD
Olanzapine—CYP3A4—liver—hypothyroidism	0.000399	0.00212	CbGeAlD
Olanzapine—CYP2D6—liver—hypothyroidism	0.000392	0.00209	CbGeAlD
Olanzapine—CYP2D6—cerebellum—hypothyroidism	0.000383	0.00204	CbGeAlD
Olanzapine—ABCB1—adrenal gland—hypothyroidism	0.000361	0.00192	CbGeAlD
Olanzapine—ABCB1—blood—hypothyroidism	0.000361	0.00192	CbGeAlD
Olanzapine—ABCB1—thyroid gland—hypothyroidism	0.000348	0.00186	CbGeAlD
Olanzapine—ABCB1—female gonad—hypothyroidism	0.000336	0.00179	CbGeAlD
Olanzapine—ABCB1—testis—hypothyroidism	0.000298	0.00159	CbGeAlD
Olanzapine—ABCB1—liver—hypothyroidism	0.000282	0.0015	CbGeAlD
Olanzapine—ABCB1—cerebellum—hypothyroidism	0.000276	0.00147	CbGeAlD
Olanzapine—HTR6—Signaling by GPCR—POMC—hypothyroidism	3.78e-05	0.000285	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—POMC—hypothyroidism	3.77e-05	0.000285	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	3.77e-05	0.000285	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—PRL—hypothyroidism	3.77e-05	0.000285	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—VAV3—hypothyroidism	3.76e-05	0.000284	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—PRL—hypothyroidism	3.76e-05	0.000284	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	3.76e-05	0.000284	CbGpPWpGaD
Olanzapine—CHRM5—GPCR downstream signaling—POMC—hypothyroidism	3.76e-05	0.000284	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	3.75e-05	0.000283	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—POMC—hypothyroidism	3.75e-05	0.000283	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—POMC—hypothyroidism	3.75e-05	0.000283	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—VAV3—hypothyroidism	3.74e-05	0.000283	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	3.74e-05	0.000282	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—PRL—hypothyroidism	3.74e-05	0.000282	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TRH—hypothyroidism	3.72e-05	0.000281	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	3.7e-05	0.00028	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TSHB—hypothyroidism	3.7e-05	0.00028	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TSHR—hypothyroidism	3.7e-05	0.00028	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—AVP—hypothyroidism	3.69e-05	0.000279	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	3.69e-05	0.000279	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—IGF1—hypothyroidism	3.68e-05	0.000278	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—POMC—hypothyroidism	3.67e-05	0.000277	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—PRL—hypothyroidism	3.66e-05	0.000277	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—SLC5A5—hypothyroidism	3.65e-05	0.000276	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TPO—hypothyroidism	3.65e-05	0.000276	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TSHB—hypothyroidism	3.64e-05	0.000275	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TSHR—hypothyroidism	3.64e-05	0.000275	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	3.64e-05	0.000275	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	3.64e-05	0.000275	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TSHR—hypothyroidism	3.64e-05	0.000275	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TSHB—hypothyroidism	3.64e-05	0.000275	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AVP—hypothyroidism	3.63e-05	0.000275	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AVP—hypothyroidism	3.63e-05	0.000274	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TSHB—hypothyroidism	3.62e-05	0.000274	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TSHR—hypothyroidism	3.62e-05	0.000274	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AVP—hypothyroidism	3.62e-05	0.000273	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TSHB—hypothyroidism	3.61e-05	0.000273	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TSHR—hypothyroidism	3.61e-05	0.000273	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—POMC—hypothyroidism	3.61e-05	0.000273	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—IGF1—hypothyroidism	3.61e-05	0.000273	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AVP—hypothyroidism	3.6e-05	0.000272	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—PRL—hypothyroidism	3.6e-05	0.000272	CbGpPWpGaD
Olanzapine—DRD1—GPCR downstream signaling—POMC—hypothyroidism	3.58e-05	0.00027	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	3.58e-05	0.00027	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TSHB—hypothyroidism	3.58e-05	0.00027	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TSHR—hypothyroidism	3.58e-05	0.00027	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AVP—hypothyroidism	3.57e-05	0.00027	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	3.57e-05	0.000269	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	3.57e-05	0.000269	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—POMC—hypothyroidism	3.56e-05	0.000269	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	3.56e-05	0.000269	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—PRL—hypothyroidism	3.55e-05	0.000268	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	3.53e-05	0.000267	CbGpPWpGaD
Olanzapine—DRD3—GPCR downstream signaling—POMC—hypothyroidism	3.53e-05	0.000267	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—VAV3—hypothyroidism	3.48e-05	0.000263	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—VAV3—hypothyroidism	3.48e-05	0.000263	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—VAV3—hypothyroidism	3.46e-05	0.000261	CbGpPWpGaD
Olanzapine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.45e-05	0.000261	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—POMC—hypothyroidism	3.45e-05	0.00026	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—PRL—hypothyroidism	3.44e-05	0.00026	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	3.43e-05	0.000259	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—POMC—hypothyroidism	3.41e-05	0.000258	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—PRL—hypothyroidism	3.4e-05	0.000257	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—VAV3—hypothyroidism	3.39e-05	0.000256	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AVP—hypothyroidism	3.36e-05	0.000254	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AVP—hypothyroidism	3.35e-05	0.000253	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—VAV3—hypothyroidism	3.33e-05	0.000252	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AVP—hypothyroidism	3.33e-05	0.000252	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	3.31e-05	0.00025	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	3.31e-05	0.00025	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	3.31e-05	0.00025	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	3.3e-05	0.000249	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—VAV3—hypothyroidism	3.29e-05	0.000248	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—POMC—hypothyroidism	3.27e-05	0.000247	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AVP—hypothyroidism	3.26e-05	0.000246	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—POMC—hypothyroidism	3.25e-05	0.000246	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	3.25e-05	0.000245	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—PRL—hypothyroidism	3.24e-05	0.000245	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—SH2B3—hypothyroidism	3.24e-05	0.000245	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—SLC5A5—hypothyroidism	3.23e-05	0.000244	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	3.23e-05	0.000244	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—SH2B3—hypothyroidism	3.22e-05	0.000243	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AVP—hypothyroidism	3.21e-05	0.000243	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—POMC—hypothyroidism	3.21e-05	0.000242	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—PRL—hypothyroidism	3.2e-05	0.000242	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	3.19e-05	0.000241	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	3.19e-05	0.000241	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—VAV3—hypothyroidism	3.18e-05	0.00024	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	3.18e-05	0.00024	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AVP—hypothyroidism	3.17e-05	0.000239	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—VAV3—hypothyroidism	3.15e-05	0.000238	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—IGF1—hypothyroidism	3.14e-05	0.000237	CbGpPWpGaD
Olanzapine—ALB—Metabolism—TSHB—hypothyroidism	3.13e-05	0.000236	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	3.08e-05	0.000233	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AVP—hypothyroidism	3.06e-05	0.000232	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	3.06e-05	0.000231	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AVP—hypothyroidism	3.03e-05	0.000229	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—VAV3—hypothyroidism	3e-05	0.000227	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	2.98e-05	0.000225	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—SLC5A5—hypothyroidism	2.97e-05	0.000224	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—VAV3—hypothyroidism	2.96e-05	0.000224	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	2.95e-05	0.000223	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	2.93e-05	0.000221	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—POMC—hypothyroidism	2.91e-05	0.00022	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—IGF1—hypothyroidism	2.91e-05	0.00022	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	2.9e-05	0.000219	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—POMC—hypothyroidism	2.89e-05	0.000218	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AVP—hypothyroidism	2.89e-05	0.000218	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PRL—hypothyroidism	2.89e-05	0.000218	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AVP—hypothyroidism	2.85e-05	0.000215	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—TSHB—hypothyroidism	2.81e-05	0.000212	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—IGF1—hypothyroidism	2.8e-05	0.000211	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—POMC—hypothyroidism	2.8e-05	0.000211	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PRL—hypothyroidism	2.79e-05	0.000211	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3C2A—hypothyroidism	2.79e-05	0.000211	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—POMC—hypothyroidism	2.78e-05	0.00021	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—IGF1—hypothyroidism	2.78e-05	0.00021	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PRL—hypothyroidism	2.77e-05	0.00021	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.75e-05	0.000208	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—TSHB—hypothyroidism	2.74e-05	0.000207	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	2.71e-05	0.000204	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	2.7e-05	0.000204	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PRL—hypothyroidism	2.7e-05	0.000204	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	2.67e-05	0.000202	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	2.66e-05	0.000201	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	2.66e-05	0.000201	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PRL—hypothyroidism	2.66e-05	0.000201	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—POMC—hypothyroidism	2.65e-05	0.000201	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	2.65e-05	0.0002	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—POMC—hypothyroidism	2.64e-05	0.000199	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	2.61e-05	0.000197	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	2.6e-05	0.000197	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—TSHB—hypothyroidism	2.58e-05	0.000195	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VAV3—hypothyroidism	2.58e-05	0.000195	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AVP—hypothyroidism	2.57e-05	0.000194	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VAV3—hypothyroidism	2.57e-05	0.000194	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—TSHB—hypothyroidism	2.56e-05	0.000193	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	2.5e-05	0.000189	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	2.5e-05	0.000189	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AVP—hypothyroidism	2.49e-05	0.000188	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AVP—hypothyroidism	2.47e-05	0.000187	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.47e-05	0.000187	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	2.46e-05	0.000186	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—POMC—hypothyroidism	2.45e-05	0.000185	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PRL—hypothyroidism	2.45e-05	0.000185	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	2.44e-05	0.000185	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	2.42e-05	0.000183	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—POMC—hypothyroidism	2.42e-05	0.000182	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—POMC—hypothyroidism	2.41e-05	0.000182	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PRL—hypothyroidism	2.41e-05	0.000182	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AVP—hypothyroidism	2.4e-05	0.000182	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PRL—hypothyroidism	2.4e-05	0.000182	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—POMC—hypothyroidism	2.4e-05	0.000181	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PRL—hypothyroidism	2.4e-05	0.000181	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—POMC—hypothyroidism	2.39e-05	0.000181	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PRL—hypothyroidism	2.39e-05	0.00018	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—POMC—hypothyroidism	2.37e-05	0.000179	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AVP—hypothyroidism	2.37e-05	0.000179	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PRL—hypothyroidism	2.37e-05	0.000179	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	2.36e-05	0.000179	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PRL—hypothyroidism	2.36e-05	0.000178	CbGpPWpGaD
Olanzapine—ALB—Metabolism—SLC5A5—hypothyroidism	2.34e-05	0.000177	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	2.3e-05	0.000174	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	2.28e-05	0.000172	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VAV3—hypothyroidism	2.26e-05	0.000171	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.25e-05	0.00017	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—POMC—hypothyroidism	2.23e-05	0.000169	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—POMC—hypothyroidism	2.23e-05	0.000168	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VAV3—hypothyroidism	2.23e-05	0.000168	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VAV3—hypothyroidism	2.22e-05	0.000168	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VAV3—hypothyroidism	2.22e-05	0.000167	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—POMC—hypothyroidism	2.21e-05	0.000167	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VAV3—hypothyroidism	2.21e-05	0.000167	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	2.2e-05	0.000166	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PRL—hypothyroidism	2.19e-05	0.000166	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VAV3—hypothyroidism	2.19e-05	0.000165	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—TSHB—hypothyroidism	2.19e-05	0.000165	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	2.18e-05	0.000165	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AVP—hypothyroidism	2.18e-05	0.000165	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—POMC—hypothyroidism	2.17e-05	0.000164	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AVP—hypothyroidism	2.15e-05	0.000162	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IGF1—hypothyroidism	2.15e-05	0.000162	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IGF1—hypothyroidism	2.14e-05	0.000162	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AVP—hypothyroidism	2.14e-05	0.000162	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AVP—hypothyroidism	2.14e-05	0.000161	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—POMC—hypothyroidism	2.13e-05	0.000161	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IGF1—hypothyroidism	2.13e-05	0.000161	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AVP—hypothyroidism	2.13e-05	0.000161	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AVP—hypothyroidism	2.11e-05	0.000159	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—POMC—hypothyroidism	2.1e-05	0.000159	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AVP—hypothyroidism	2.1e-05	0.000159	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—SLC5A5—hypothyroidism	2.1e-05	0.000159	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IGF1—hypothyroidism	2.09e-05	0.000158	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IGF1—hypothyroidism	2.05e-05	0.000155	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.05e-05	0.000155	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—POMC—hypothyroidism	2.04e-05	0.000154	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	2.03e-05	0.000153	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IGF1—hypothyroidism	2.02e-05	0.000153	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—POMC—hypothyroidism	2.02e-05	0.000152	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IGF1—hypothyroidism	1.96e-05	0.000148	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AVP—hypothyroidism	1.95e-05	0.000148	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	1.95e-05	0.000147	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IGF1—hypothyroidism	1.94e-05	0.000146	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.93e-05	0.000146	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.92e-05	0.000145	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—POMC—hypothyroidism	1.92e-05	0.000145	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—SLC5A5—hypothyroidism	1.92e-05	0.000145	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—POMC—hypothyroidism	1.91e-05	0.000144	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—POMC—hypothyroidism	1.9e-05	0.000143	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IGF1—hypothyroidism	1.85e-05	0.00014	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IGF1—hypothyroidism	1.82e-05	0.000138	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—POMC—hypothyroidism	1.71e-05	0.000129	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—POMC—hypothyroidism	1.69e-05	0.000128	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TSHB—hypothyroidism	1.69e-05	0.000128	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—POMC—hypothyroidism	1.65e-05	0.000125	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	1.65e-05	0.000124	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—POMC—hypothyroidism	1.64e-05	0.000124	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—SLC5A5—hypothyroidism	1.64e-05	0.000124	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—POMC—hypothyroidism	1.6e-05	0.000121	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IGF1—hypothyroidism	1.59e-05	0.00012	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IGF1—hypothyroidism	1.58e-05	0.000119	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—POMC—hypothyroidism	1.57e-05	0.000119	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—POMC—hypothyroidism	1.55e-05	0.000117	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	1.54e-05	0.000116	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	1.51e-05	0.000114	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.51e-05	0.000114	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—POMC—hypothyroidism	1.45e-05	0.00011	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—POMC—hypothyroidism	1.43e-05	0.000108	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—POMC—hypothyroidism	1.42e-05	0.000108	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—POMC—hypothyroidism	1.42e-05	0.000107	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—POMC—hypothyroidism	1.41e-05	0.000107	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—POMC—hypothyroidism	1.4e-05	0.000106	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—POMC—hypothyroidism	1.4e-05	0.000106	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IGF1—hypothyroidism	1.39e-05	0.000105	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IGF1—hypothyroidism	1.37e-05	0.000104	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IGF1—hypothyroidism	1.37e-05	0.000103	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IGF1—hypothyroidism	1.37e-05	0.000103	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IGF1—hypothyroidism	1.36e-05	0.000103	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IGF1—hypothyroidism	1.35e-05	0.000102	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	1.34e-05	0.000102	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—POMC—hypothyroidism	1.3e-05	9.81e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.26e-05	9.55e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	1.25e-05	9.43e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—POMC—hypothyroidism	1.23e-05	9.26e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—POMC—hypothyroidism	1.1e-05	8.31e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—POMC—hypothyroidism	1.07e-05	8.11e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—POMC—hypothyroidism	1.01e-05	7.64e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—POMC—hypothyroidism	1e-05	7.58e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—POMC—hypothyroidism	8.57e-06	6.47e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—POMC—hypothyroidism	6.61e-06	5e-05	CbGpPWpGaD
